Jessen, Julia
Höffken, Oliver
Schwenkreis, Peter
Tegenthoff, Martin
Özgül, Özüm Simal
Enax-Krumova, Elena
Article History
Received: 11 March 2024
Accepted: 9 July 2024
First Online: 15 July 2024
Competing interests
: The authors declare no conflict of interest related to the studied topic. E.E.-K. has received personal fees from Novartis GmbH, Casquar GmbH, OmegaPharma GmbH and painCert GmbH.